2 months ago
GMED
AnalystsVik ChopraVik Chopra's Stock Forecasts
AnalystsVik Chopra
Analyst Ranking
Top 24%
#1252 out of 5266 analysts
Average Return
+8.72%
Win Rate
53%16 out of 30
Risk vs Reward
Poor
Good
Vik Chopra's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neuropace IncNPCE | +83.15% | $9.32 | $17.07 | 2025-08-12 - 2026-05-01 | Strong Buy |
Alphatec Holdings IncATEC | +59.34% | $6.64 | $10.58 | 2024-07-31 - 2025-07-31 | Strong Buy |
Globus Medical IncGMED | +55.74% | $58.65 | $91.34 | 2025-08-07 - 2026-05-01 | Strong Buy |
Neuropace IncNPCE | +47.54% | $9.15 | $13.50 | 2024-11-12 - 2025-11-12 | Strong Buy |
Align Technology IncALGN | +38.68% | $129.01 | $178.91 | 2025-07-30 - 2026-05-01 | Strong Buy |
Vik Chopra Analyst Color
Get additional color on Vik Chopra's coverage of popular stocks
a year ago
MASI
Vik Chopra's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Solventum CorpSOLV | 6 | Hold | $83.00 | +24.57% | Maintains | 2 months ago |
Integra Lifesciences Holdings CorpIART | 3 | Hold | $12.00 | +9.59% | Maintains | 2 months ago |
Dentsply Sirona IncXRAY | 5 | Hold | $13.00 | +10.08% | Maintains | 2 months ago |
Globus Medical IncGMED | 12 | Strong Buy | $104.00 | +13.86% | Maintains | 2 months ago |
Henry Schein IncHSIC | 4 | Hold | $87.00 | +17.68% | Maintains | 2 months ago |
Masimo CorpMASI | 11 | Hold | $180.00 | +0.85% | Downgrades | 2 months ago |
Envista Holdings CorpNVST | 4 | Hold | $26.00 | -1.25% | Maintains | 3 months ago |
Align Technology IncALGN | 5 | Strong Buy | $200.00 | +11.79% | Maintains | 3 months ago |
Conmed CorpCNMD | 7 | Hold | $42.00 | +14.13% | Maintains | 3 months ago |
Enovis CorpENOV | 5 | Strong Buy | $42.00 | +77.82% | Maintains | 6 months ago |
Neuropace IncNPCE | 4 | Strong Buy | $16.00 | -6.27% | Maintains | 6 months ago |
Alphatec Holdings IncATEC | 2 | Strong Buy | $16.00 | +53.40% | Maintains | 7 months ago |
Nuvasive IncNUVA | 2 | Hold | $57.72 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.